Additionally, EGFR-2-over-expressed SK-BR-3 breast cancer cells, and the growth of estrogen receptor-bearing MCF-7 breast cancer cells was inhibited by the treatment of fisetin. The gene discussed is EGFR; the disease is breast carcinoma.